Erythromelanosis follicularis faciei <i>et</i> colli: Relationship with keratosis pilaris
نویسندگان
چکیده
منابع مشابه
Erythromelanosis follicularis faciei et colli with reticulated hyperpigmentation of the extremities
Erythromelanosis follicularis faciei et colli (EFFC) is a distinct, rare, and underdiagnosed condition of unknown etiology that is characterized by well-demarcated erythema, hyperpigmentation, and follicular papules. The pigmentation is usually on both maxillary, preauricular regions, and the cheeks. We report a case of a 12-year-old boy with EFFC that was associated with reticulated pigmentati...
متن کاملErythrosis pigmentosa mediofacialis (Brocq) and erythromelanosis follicularis faciei et colli in the same patient.
Erythrosis pigmentosa peribuccalis (Brocq) (or erythrosis pigmentosa mediofacialis) and erythromelanosis follicularis faciei et colli, have been regarded as different disorders, mainly because the first occurs on the mediofacial area and is common in women and the second mostly occurs pre-auricularly in men. Both conditions show histological signs of abnormal follicular keratinization with tele...
متن کاملErythromelanosis Follicularis Faciei: A Case Report and Review of the Literature.
Erythromelanosis follicularis faciei is a rare sporadic condition of unknown etiology characterized by reddish-brownish patches and follicular papules that appear commonly on the face and rarely on the neck. Herein, we report a 16-year-old male who had asymptomatic facial skin lesions since early childhood. His family history revealed a similar case in his younger brother. His parents are not c...
متن کاملLong-pulsed dye laser for the treatment of erythromelanosis follicularis faciei: report of two clinical cases.
Two Japanese men complained of redness of their jowls and requested treatment of those areas. Examination revealed welldemarcated reddish-brown pigmentation with granular texture on both sides of the cheeks. The redness of the lesion was mainly caused by dilation of superficial vessels and vanished when pressure was applied. Both patients were diagnosed as EFF by the classical triad, which is c...
متن کاملNilotinib-Induced Keratosis Pilaris
Nilotinib is a second-generation Bcr-Abl tyrosine kinase inhibitor (TKI) that is approved for the treatment of imatinib-resistant chronic myeloid leukaemia expressing the Bcr-Abl mutation. Cutaneous adverse drug reactions occur more frequently in patients using this medication. We present a case of nilotinib-induced keratosis pilaris that did not have accompanying symptoms of alopecia or prurit...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Indian Journal of Dermatology, Venereology and Leprology
سال: 2008
ISSN: 0378-6323
DOI: 10.4103/0378-6323.38409